Bikash Chatterjee

President and Chief Scientific Officer
Pharmatech Associates

Mr. Chatterjee, President and Chief Scientific Officer for Pharmatech Associates, has been in the bio-pharmaceutical, pharmaceutical, medical device and diagnostics industry for over 30 years. He has guided the successful approval of over a dozen products across U.S. and Europe and is a frequent speaker at industry and regulatory events.

Articles by Bikash Chatterjee

  • Supply Chain Trends: Domestic and International Regulations

    Tuesday, May 28, 2019
    One of the inevitable consequences of political change is disruption to the global economic engine. Disruption can result from political instability, regulation, or even innovation. Now, from the portent of the coming Brexit storm, to the enactment ...
  • Selecting and Qualifying a Regenerative Medicine CMO

    Thursday, October 04, 2018
    Among the most remarkable technical advances seen within the healthcare sector over the last decade is the fast growing sector of regenerative medicine. Breakthrough technologies are empowering re- generative medicine through the introduction of new,...
  • The Right Stuff: Making the Transition from Development to Commercial Manufacturing with Your CMO

    Tuesday, March 20, 2018
    The emergence of virtual biotech, specialty drug delivery companies and the increase in the number of in-licensed and collaboration development programs has spawned a new generation of Contract Manufacturing Organizations (CMOs) offering services ...
  • An Argument for Change – The Promise of the Next Decade

    Monday, September 25, 2017
    Over a decade ago I wrote an article advocating that industry and FDA truly embrace the 2004 FDA guidance, which supported a shift from a documentation - and testing framework for assessing quality and compliance to one predicated on scientific ...
  • 2016 Wrap-Up: Looking Ahead to 2017 and Beyond

    Sunday, November 20, 2016
    As we bid farewell to 2016 to face the opportunities and challenges of 2017, the global life sciences industry can be best described as being on the cusp of great change. For the last ten years, U.S. market growth has been transitory, with M&A ...
  • Managing Cold Chain Distribution Across the Global Supply Chain: Trends and Regulations

    Thursday, July 21, 2016
    Supply chains now span the globe and are increasing in complexity as organizations move away from regional business models to manufacturing and distribution on a world scale. A critical byproduct of good manufacturing practice (GMP), an unbroken ...
  • The Contract Service Provider Compact

    Wednesday, September 30, 2015
    Contract manufacturing organizations are our industry partners. There are few strategic and tactical plans within the global life sciences that do not include an outsourcing element. The maturation of the Indian and Chinese markets has created ...
  • A Framework for Managing Supply Chain Integrity and Supplier Quality

    Thursday, May 28, 2015
    Ensuring supply chain integrity today in the global market requires integrating risk management for a physical and a virtual supply chain. An approach that ensures supplier quality and performance and supply chain integrity is very important. The ...
  • <<
  • >>